Berardi R - Search Results

1

Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab.

Giampieri R, Lupi A, Ziranu P, Bittoni A, Pretta A, Pecci F, Persano M, Giglio E, Copparoni C, Crocetti S, Mandolesi A, Faa G, Coni P, Scartozzi M, Berardi R. Giampieri R, et al. Among authors: berardi r. Front Oncol. 2021 Sep 30;11:736104. doi: 10.3389/fonc.2021.736104. eCollection 2021. Front Oncol. 2021. PMID: 34660299 Free PMC article.

2

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

Berardi R, Scartozzi M, Galizia E, Cascinu S. Berardi R, et al. Suppl Tumori. 2003 Sep-Oct;2(5):S45-7. Suppl Tumori. 2003. PMID: 12914390 Review.

3

Gastric cancer treatment: a systematic review.

Berardi R, Scartozzi M, Romagnoli E, Antognoli S, Cascinu S. Berardi R, et al. Oncol Rep. 2004 Apr;11(4):911-6. Oncol Rep. 2004. PMID: 15010894 Review.

4

[Non-small cell lung carcinoma: pathology, biology and prognosis].

Freddari F, Berardi R, Scartozzi M, Cascinu S. Freddari F, et al. Among authors: berardi r. Suppl Tumori. 2004 Mar-Apr;3(2):S3-4. Suppl Tumori. 2004. PMID: 15067954 Italian. No abstract available.

5

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.

Scartozzi M, Galizia E, Freddari F, Berardi R, Cellerino R, Cascinu S. Scartozzi M, et al. Among authors: berardi r. Cancer Treat Rev. 2004 Aug;30(5):451-9. doi: 10.1016/j.ctrv.2004.01.001. Cancer Treat Rev. 2004. PMID: 15245777 Review.

6

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.

Graziano F, Mandolesi A, Ruzzo A, Bearzi I, Testa E, Arduini F, Silva R, Muretto P, Mari D, Berardi R, Scartozzi M, Lai V, Cascinu S, Magnani M. Graziano F, et al. Among authors: berardi r. Tumour Biol. 2004 May-Jun;25(3):106-10. doi: 10.1159/000079141. Tumour Biol. 2004. PMID: 15361706 Clinical Trial.

7

A cost-benefit analysis of chemotherapy for gastric cancer.

Galizia E, Berardi R, Scartozzi M, Cascinu S. Galizia E, et al. Among authors: berardi r. Expert Opin Pharmacother. 2004 Oct;5(10):2109-14. doi: 10.1517/14656566.5.10.2109. Expert Opin Pharmacother. 2004. PMID: 15461546 Review.

8

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S. Scartozzi M, et al. Among authors: berardi r. J Clin Oncol. 2004 Dec 1;22(23):4772-8. doi: 10.1200/JCO.2004.00.117. J Clin Oncol. 2004. PMID: 15570078

9

New frontiers in the neoadjuvant therapy of pancreatic adenocarcinoma: apart from therapeutical protocols.

Berardi R, Verdecchia L, Scartozzi M, Cascinu S. Berardi R, et al. JOP. 2005 Jan 13;6(1 Suppl):118-21. JOP. 2005. PMID: 15650296 Review. No abstract available.

10

Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy.

Berardi R, Saladino T, Mari D, Silva RR, Scartozzi M, Verdecchia L, Onofri A, Cascinu S. Berardi R, et al. Tumori. 2005 Nov-Dec;91(6):463-6. doi: 10.1177/030089160509100603. Tumori. 2005. PMID: 16457142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters